🔎 Trials Near Me

Home › Essential Thrombocythemia › New York › New York City

Essential Thrombocythemia clinical trials in New York City, NY

7 studies for Essential Thrombocythemia are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

RecruitingPhase 2
  • NYP/Weill Cornell Medical Center, New York
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT06661915

A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

RecruitingPhase 3
  • Icahn School of Medicine At Mount Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • Weill Cornell Medical College - Newyork-Presbyterian Hospita, New York
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07623200

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

RecruitingPhase 1
  • Icahn School of Medicine At Mount Sinai, New York
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07008118

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

RecruitingPhase 1
  • Memorial Sloan Kettering Cancer Center, New York
  • Mount Sinai School of Medicine, New York
  • Weill Cornell Medicine, New York
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07441694

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

RecruitingPhase 1
  • Icahn School of Medicine At Mount Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
Ages 18 and older · All sexes · Updated Apr 17, 2026 · NCT06034002

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

RecruitingObservational study
  • Memorial Sloan Kettering Cancer Center, New York
Ages 18 and older · All sexes · Updated Jan 23, 2026 · NCT07362225

MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial

RecruitingPhase 2
  • Ruttenberg Treatment Center, New York
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT06541249

Essential Thrombocythemia trials in other cities

Other studies in New York City

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.